LAVA Therapeutics NV (LVTX) Quote

LVTX under $2

LVTX, under $2

LVTX.................................https://stockcharts.com/h-sc/ui?s=LVTX&p=W&b=5&g=0&id=p86431144783

LAVA Announces Evaluation of Strategic Options
Advisor engaged in evaluating strategic options to maximize shareholder value

Cash balance of $76.6 million as of December 31, 2024

UTRECHT, The Netherlands and PHILADELPHIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” “the Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, announced that the Company has initiated a process to review strategic options focused on maximizing shareholder value and has implemented cost curtailment including a workforce reduction. The Company has retained an experienced financial advisor to support LAVA with the strategic evaluation process. LAVA will continue to enroll in the Phase 1 clinical study evaluating the safety and pharmacokinetics of LAVA-1266 in hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and support its partnerships with Pfizer and Johnson and Johnson.

“While we will continue investigating LAVA-1266 in the potential treatment of AML and MDS and supporting our Gammabody pharma partnerships, with only one product in clinical development and an early-stage pipeline, we felt it appropriate to investigate strategic opportunities to drive additional shareholder value. LAVA is in a strong position to unlock strategic opportunities for the Company, in addition to our proprietary pipeline and partnered programs,” said Steve Hurly, Chief Executive Officer of LAVA.

The Company will explore and evaluate diverse strategic options to maximize shareholder value, including in-licensing of assets, a sale, licensing agreement, merger, acquisition, or other strategic transactions. There can be no assurance that this process will result in any such transaction. LAVA’s Board of Directors has not set a timetable for the strategic review process. LAVA does not intend to provide updates until the Board approves a specific action or otherwise determines that disclosure is appropriate or required.

In connection with the evaluation of strategic alternatives, LAVA is implementing a restructuring plan that includes a workforce reduction of approximately thirty percent, furthering cost-containment and cash conservation measures. The Company intends to retain all employees essential for supporting value creation as part of its strategic review. The Company estimates that it will incur approximately $0.5 million of one-time costs primarily incurred in Q1 2025 related to the workforce reduction.

“I want to express my sincere gratitude to each of our employees being affected by this workforce reduction,” said Mr. Hurly. “We thank them for their dedicated service and contribution to LAVA’s mission to advancing the portfolio of bispecific T cell engagers and our proprietary Gammabody platform.”

As of December 31, 2024, the Company’s cash, cash equivalents, and investments were $76.6 million (unaudited)

LVTX..................https://stockcharts.com/h-sc/ui?s=LVTX&p=W&b=5&g=0&id=p86431144783

LVTX under $2

LVTX 10Q due AUGUST 19

Quiet before storm!

LVTX under $3

LVTX.............................https://stockcharts.com/h-sc/ui?s=LVTX&p=W&b=5&g=0&id=p86431144783

LVTX under $2

Pfizer could really use this compound and they are not making it a secret.
Its a falling knife as many others are right now but you are getting pennies on the dollar in my opinion.

Put in quite a bar in late February. Its because those in the know wanted shares.

Very little these days

The chart really has it all... Do you consider fundamentals?

Like the chart

PFE darling and pretty chart.

Looking to break $4 for good.
Consolidating at $3.90's.
Hope it's not going to be double top fail.
Time will tell.

LVTX..............................https://stockcharts.com/h-sc/ui?s=LVTX&p=W&b=5&g=0&id=p86431144783

Excellent week.
Hopefully $4 next week.

Beautiful chart. Breakout past $3.30 to. $3.35.
Lots of cash.
Looking for at least $5 soon. Maybe more.
JMO.

LVTX 10Q due 3/22

Nice bounce back above $3.
Would love another run to $3.25.
I think this has good chance to move to $4 sooner or later. Lots of cash.
JMO

Crazy stock dropped on earnings news which means nothing IMO.
Typical sell on news. Stock will need to regroup before it can retest $3.
They have huge amounts of cash and good partners.
I am holding through this sell off.

Interesting. Trying to breakout.
Needs news.

Nice chart. They have cash to last until 2026.
Needs to breakout past $3 with volume.
Tried several times but failed.

LVTX.........................................https://stockcharts.com/h-sc/ui?s=LVTX&p=W&b=5&g=0&id=p86431144783

LVTX.................................................https://stockcharts.com/h-sc/ui?s=LVTX&p=W&b=5&g=0&id=p86431144783

LVTX new 52 week high

Nice pump today sold some shares made a bundle ….weeeeeeeeeee

Insider and institutional ownership here are pretty big numbers. With the Merck partnership this should be heading North when the dip buying resolves..... This will soon be a battle ground between $3 and $4!

I hit this for a few more shares at 1.96 in Pre-market. I read some further and like the Merck Deal and that fact that they have the Balance Sheet Strength to partner with them!!!! Let's see how long I have to hold on to this, for it to Double from here!!!!

LVTX: I think we ALL eventually learned today this THIS ONE is a dud!!! (DAMN-IT!!!)

WHAT DID I TEACH YOU LAST TIME : KNEEL AND OBEY YOUR MASTER !!

WATCH AND LEARN LOSER

LVTX: And there she goes!! (That MERCK name can do things, ya know.)

LVTX: The heck with those "SXTC-like", Chinese BAD-Fortune-Cookie routines!! Check-out the LVTX 'Bollinger-Curves' on MY cute 'Scanners'!! (See below!!)

"I suddenly feel a Short-SQUEEZE of sorts comin' on!! Can ya all help-me-out a little bit, Fellas??!!"
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

OK SO NOW YOU'RE A MIND READER !! SIMPLY AMAZING !!
SO KEEP INVESTING IN THESE MICKEY MOUSE STOCKS, MAYBE ONE DAY THE LOTTO
IS IN YOUR FUTURE. ONE MORE REMINDER : ALWAYS LISSSSSSSSSSSSSSSSSSSSTEN TO YOUR MASTER !!

you own nothing...go back to work....you're lunch break is almost over

THE MARKET SELL OFF I COMING VERY SOON. EVEN THOUGH I'M LONG, GOT PLENTY OF PROTECTION.

crown what happen to the market crash you keep telling people...stick to the trolling son...fake traders never lose!!!

YOU MEAN THE MASTER TRADER OF ALL TIMES !!
OK SENIOR; VERY SIMPLE REALLY; STICK WITH MSFT, NVDA, AMZN GOOG, AND META.
DON'T OVRERTHINK IT.

coming from one of the great ihub traders i should listen to you...what are you buying these days big fella

SELL !!

LVTX...COME ON YOU CAN DO IT

LVTX NEXT BIOP BEAST DAY TRADER

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Bought some Dip..... May pick up some more if the Morning Open get's a pullback...... Good one for a Move up into weekend!!!!!

LVTX 2.74= $$

$LVTX 2.44 I BOUGHT 1.92'S, YOU IN?

Cash Position The company has 28.7 months of cash left based on quarterly cash burn of -$9.62M and estimated current cash of $92.1M.
https://dilutiontracker.com/app/search/LVTX